1. Virani SA, Dent S, Johnson C, et al. Canadian Cardiovascular Society Position Statement: evaluation of patients at risk of CV complications of cancer therapy. Presented at: the Canadian Cardiovascular Congress. October 24-26, 2015; Toronto, Ontario, Canada.
2. American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants;Hensley;J Clin Oncol,2009
3. Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines;Curigliano;Ann Oncol,2012
4. Adding “value” to clinical practice guidelines;McCormack;Can Fam Physician,2007
5. Cardioprotective interventions for cancer patients receiving anthracyclines;van Dalen;Cochrane Database Syst Rev,2011